Fluconazole Dosing for Coccidioidomycosis

Recommended Dosing for Coccidioidomycosis

The Infectious Diseases Society of America (IDSA) recommends fluconazole 400-1200mg orally daily as initial therapy for coccidioidal meningitis and most forms of coccidioidomycosis in patients with normal renal function 1, 2
For extrapulmonary soft tissue coccidioidomycosis, oral azoles, particularly fluconazole or itraconazole, are recommended as first-line therapy 1
For transplant recipients with coccidioidomycosis who are clinically stable with normal renal function, fluconazole 400mg daily is recommended 1

For coccidioidal meningitis, fluconazole 400-1200mg daily is recommended with no role for doses below 400mg daily in adult patients without substantial renal impairment 3
In cases of bone and joint coccidioidomycosis, higher doses of fluconazole (minimum 800mg daily) may be needed based on comparative studies with itraconazole 4
For patients who fail initial therapy with fluconazole, increasing the dose is recommended as a first option before considering alternative treatments 3

For coccidioidal meningitis, lifelong azole treatment is recommended due to high relapse rates when therapy is discontinued 3
For non-meningeal forms, treatment duration varies from 6-12 months to several years depending on disease severity and host immune status 5

When initiating fluconazole therapy, start with the recommended 400mg once daily dose rather than dividing it into 200mg twice daily 1, 2
For patients with severe or rapidly progressing disease, consider amphotericin B initially until stabilized, followed by fluconazole 1
In immunocompromised patients, particularly transplant recipients, reduction of immunosuppression may be necessary alongside antifungal therapy 1